Antiepileptic therapy in patients with central nervous system malignancies

Current Neurology and Neuroscience Reports

Volumn 6, Issue 4, 2006, Pages 311-318

  Stevens, Glen H J ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CIMETIDINE; CIPROFLOXACIN; DILTIAZEM; ETIRACETAM; FELBAMATE; FLUOXETINE; GABAPENTIN; ISONIAZID; KETOCONAZOLE; LAMOTRIGINE; MACROLIDE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; STEROID; SUCRALFATE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; WARFARIN; ZONISAMIDE;

AGGRESSION; AGITATION; ANOREXIA; ANTICONVULSANT THERAPY; APLASTIC ANEMIA; ASTHENIA; ATAXIA; BEHAVIOR MODIFICATION; BLOOD DYSCRASIA; BLURRED VISION; BODY WEIGHT DISORDER; BRAIN CANCER; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CALCULATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RADIOTHERAPY; CHOREOATHETOSIS; CLINICAL FEATURE; COGNITIVE DEFECT; DIET THERAPY; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG METABOLISM; DYSTONIA; ENDOCRINE DISEASE; EVIDENCE BASED MEDICINE; FATIGUE; GAMMA KNIFE RADIOSURGERY; GLAUCOMA; HEADACHE; HEALTH CARE ORGANIZATION; HUMAN; HYPERACTIVITY; HYPNOSIS; HYPONATREMIA; IRRITABILITY; KIDNEY CLEARANCE; KIDNEY FAILURE; LETHARGY; LEUKOPENIA; LIFESTYLE; LIVER FAILURE; LIVER TOXICITY; MAINTENANCE DRUG DOSE; MEDICAL SPECIALIST; MOTOR DYSFUNCTION; MULTIVARIATE ANALYSIS; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; NYSTAGMUS; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PARESTHESIA; PERIPHERAL EDEMA; PROGNOSIS; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; SEDATION; SEIZURE; SOMNOLENCE; TREMOR; UNITED STATES; VAGUS NERVE STIMULATION; VOMITING;

ANTICONVULSANTS; BRAIN NEOPLASMS; COMPLEMENTARY THERAPIES; ELECTRIC STIMULATION THERAPY; HUMANS; RADIOTHERAPY; SEIZURES;

EID: 33746052455     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-006-0024-9     Document Type: Review

References (49)

1. Primary Brain Tumors in the United States: Statistical Report. Chicago, IL: Central Brain Tumor Registry of the United States; 1997-2001.
2. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics. Cancer J Clin 1999, 49:8-31.
3. Glantz MJ, Cole BF, Forsyth PA, et al.: Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000, 54:1886-1893.
4. Sirven JI, Wingerchuk DM, Drazkowski JF, et al.: Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 2004, 79:1489-1494.
5. Sirven JI: Classifying seizures and epilepsy: a synopsis. Semin Neurol 2002, 22:237-246.
6. French JA, Kanner AM, Bautista J, et al.: Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004, 45:401-409.
7. French JA, Kanner AM, Bautista J, et al.: Efficacy and tolerability of the new antiepileptic drugs, II: treatment of new-onset epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004, 45:401-409.
8. Kessler RC, Bavis RB, Foster DF, et al.: Long-term trends in the use of complimentary and alternative medical therapies in the United States. Ann Intern Med 2001, 135:262-268.
9. Eisenbery DM, Davis RB, Ettner SL, et al.: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575.
10. Hariharan S, Landolfi J, More J, et al.: Alternative therapy use by malignant glioma patients: data from the glioma outcomes project. Neuro-oncol 2000, 2:268.
11. Chang SM, Parney IF, Haung MS, et al.: Patterns of care for adults with newly diagnosed malignant glioma. JAMA 2005, 293:557-564.
12. Verhoef MJ, Hagan N, Pelletier G, Forsyth P: Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 1999, 52:617-622.
13. Plunkett M, Klein E, Alldredge B: Use of complimentary and alternative medicine products by patients with epilepsy. How common is it? Epilepsia 2004, 45 (Suppl 7):149.
14. Khoi DT, Kossoff EH, Rubenstrein JE, et al.: Can you predict immediate, complete, and sustained response to the ketogenic diet? Epilepsia 2005, 46:580-582.
15. Nebeling LC, Miraldi F, Shurin SB, Lerner E: Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 1995, 14:202-208.
16. Cole AJ: Initial individualized selection of long-term anticonvulsants drugs by neurologists. Neurology 2004, 63(Suppl 4):S1-S2.
17. Vecht CJ, Wagner GL, Wilms EB: Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 2003, 30(Suppl 19):49-52.
18. Perry JR, Sawaka C: Add-on gabapentin for refractory seizures in patients with brain tumors. Can J Neurol Sci 1996, 23:128-131.
19. Newton HB, Goldlust S, Pearl D: Retrospective analysis of levetiracetam for the treatment of seizures in brain tumor patients. Neurology 2005, 64(Suppl 1):A47.
20. Larson SE, Sirven JI, Drazkowski JF, Zimmerman RS: Efficacy and tolerability of levetiracetam in patients with brain tumors and seizures. Epilepsia 2004, 45 (Suppl 7):124.
21. Penovch PE, Dickens DL, Gates JR, et al.: Treating seizures due to brain neoplasms: rational new choices. Epilepsia 2004, 45(Suppl 7):311.
22. Wagner GL, Wilms EB, Van Donselaar CA, Vecht CHJ: Levetiracitam: preliminary experience in patients with primary brain tumors. Seizure 2003, 12:585-586.
23. Stevens GH, Vogelbaum MA, Suh JH, et al.: Levetiracetam use in brain tumor patients. Neurology 2005, 64(Suppl 1):A48.
24. Wrighton SA, Stevens JC: The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992, 22:1-21.
25. Nelson DR, Koymans L, Kamataki T, et al.: P450 super family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6:1-42.
26. Gilbert MR, Supko JG, Batchelor T et al.: Phase I clinical trial and pharmacokinetics study of irinotecan in adults with recurrent malignant glioma. Clin Cancer Res 2003, 9:2940-2949.
27. Fetell MR, Grossman SA, Fischer JD, et al.: Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. J Clin Oncol 1997, 15:3121-3128.
28. Bourg V, Lebrun C, Chichmahian RM, et al.: Nitrosoureacisplatinum based chemotherapy associated with valproate: increase of haematologic toxicity. Ann Oncol 2001, 12:217-219.
29. Bittigua P, Sifringer M, Genz K, et al.: Antineoplastic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002, 99:15089-15094.
30. Jaeckle K, Ballman K, Uhm J, et al.: Relationship of administration of enzyme-inducing anticonvulsants (EIAC) to survival in patients with glioblastoma: a North Central Cancer treatment Group (NCCTG) study. Neuro-oncol 2004, 6:376.
31. Chalifoux R, Elisevich K: Effect on ionizing radiation on partial seizures attributable to malignant cerebral tumors. Stereotact Funct Neurosurg 1996, 97:169-182.
32. Rogers L, Morris H, Lupica K: Effect of cranial irradiation on seizure frequency in adults with low grade astrocytomas and medically intractable epilepsy. Neurology 1993, 43:1599-1601.
33. Hwang SL, Lin CL, Lee KS, et al.: Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir (Wein) 2004, 146:589-594.
34. Regis J, Bartolomei F, Rey M, et al.: Gamma knife surgery for mesial temporal lobe epilepsy. J Neurosurg 2000, 93 (Suppl 3):141-146.
35. Regis J, Rey M, Bartolomei F, et al.: Gamma knife surgery in mesial temporal lobe epilepsy: a prospective multicenter study. Epilepsia 2004, 45:504-515.
36. Wyllie ER, Luders H, Morris HH III, et al.: Clinical outcome after complete or partial resection for intractable epilepsy. Neurology 1987, 37:1634-1641.
37. Berger MS, Ghatan S, Haglund MM, et al.: Low grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg 1993, 79:62-69.
38. Wen PY, Marks PW: Medical management of patients with brain tumors. Curr Opin Oncol 2002, 14:299-307.
39. Jooma R, Yeh HS, Privitera MD, Gartner M: Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures. J Neurosurg 1995, 83:231-236.
40. Labar D, Murphy J, Tecoma E: Vagus nerve stimulation for medication-resistant generalized epilepsy. EO4 Study Group Neurology 1999, 52:1510-1512.
41. Karceski S: Devices in the treatment of epilepsy. Semin Neurol 2002, 22:259-268.
42. Ng M, Devinsky O: Vagus nerve stimulation for refractory idiopathic generalized epilepsy. Seizure 2004, 13:176-178.
43. Wilder BJ: Vagal nerve stimulation. In Epilepsia: A Comprehensive Textbook. Edited by Engle J Jr, Pedley TA. Philadelphia: Lippincott-Raven; 1997:1353-1358.
44. Fischer RS, Mirski M, Krauss G: Brain stimulation. In Epilepsy: A Comprehensive Textbook. Edited by Engle J Jr, Pedley TA Philadelphia: Lippincott-Raven; 1997:1867-1875.
45. Fischer RS, Uematsu S, Kraus GL, et al.: Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia 1992, 33:841-851.
46. Bergey GK, Britton JW, Cuscino GD, et al.: Implementation of an external responsive neurostimulator in patients with intractable epilepsy undergoing intracranial seizure monitoring. Epilepsia 2002, 43(Suppl 7):191.
47. Kubota F, Kifune A, Shibata N, et al.: Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res 1999, 33:93-97.
48. Hahn TJ, Birge SJ, Scara CR, et al.: Phenobarbital induced alterations in vit D metabolism. J Clin Invest 1972, 51:741-748.
49. Ensrund WE, Walczak TS, Blackwell T: Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 2004, 62:2051-2057.